Clinical trial Recruiting at 2 sites Interventional Ages 4 to 17

Digital support system for treating childhood obesity

Official title: A Randomized Controlled Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment (EurEvira)

Run by Karolinska Institutet · NCT04917601 · Data updated 2026-11-12

This study tests if a new digital support system called Evira can help kids aged 4 to 17 manage their weight better when combined with regular lifestyle treatment.

Quick facts

Study typeInterventional
Ages4 Years to 17 Years
SexAll
Enrollment680 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations5 sites (Messina and 4 other locations)
StatusRecruiting
StartedMay 24, 2022
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedOctober 6, 2025
Trial IDNCT04917601 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 4 to 17 years with obesity defined by a BMI of 30 to 40 kg/m2.

Probably not a fit

Patients with morbid obesity (BMI > 40 kg/m2) or certain endocrine and metabolic disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Evira, a digital support system designed to assist in the treatment of childhood obesity. It involves daily self-monitoring of weight through a special scale and a mobile app that facilitates communication between parents and clinicians. The study aims to determine if adding Evira to existing lifestyle treatment improves weight management outcomes for children aged 4 to 17 years. Participants will be randomly assigned to receive either the Evira Care treatment or standard lifestyle care.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the management of childhood obesity, leading to better health outcomes for affected children.

How similar studies have gone: Other studies have shown promise in using digital health interventions for obesity management, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>4.0 and \<17.0 years of age at inclusion
* Obesity defined based on the International Obesity Task Force criteria iso-BMI 30 - 40 kg/m2
* Willingness to participate in an obesity treatment clinical trial
* Family ability to communicate in the language of the country of residence e.g. write and read messages in the mobile application
* Parents having a smart phone and an email address

Exclusion Criteria:

* Morbid obesity defined as iso-BMI\>40kg/m2 independently of age
* Endocrine disorders other than well controlled hypothyroidism
* Metabolic disorders of importance for weight control - to be discussed
* Treatment for depression and other psychiatric disorders during the last 6 months before inclusion
* Pharmacological treatment of importance for weight control
* Hypothalamic or monogenic obesity, e.g. syndromes and Mb Down
* Severe neuropsychiatric disorders that could affect study compliance
* Eating disorders requiring therapy during the last six months before inclusion or observed at the inclusion screening.

Where it's running

  • University of Campania Luigi Vanvitelli
    Naples, Italy
    Recruiting
  • Samodzielny Publiczny Szpital Kliniczny
    Szczecin, Poland
    Recruiting
  • University of Messina
    Messina, Italy
    Not yet recruiting
  • St. Olavs Hospital
    Trondheim, Norway
    Active not recruiting
  • Kalmar barnklinik
    Kalmar, Sweden
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.